![Abstract WP327: CHADSVASC and HASBED Scores in Patients With Intracerebral Hemorrhage and Atrial Fibrillation | Stroke Abstract WP327: CHADSVASC and HASBED Scores in Patients With Intracerebral Hemorrhage and Atrial Fibrillation | Stroke](https://www.ahajournals.org/cms/asset/84f5127b-c892-4f10-a683-0de3d5087f8d/g3912.jpg)
Abstract WP327: CHADSVASC and HASBED Scores in Patients With Intracerebral Hemorrhage and Atrial Fibrillation | Stroke
![The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis - Zhu - 2015 - Clinical Cardiology - Wiley Online Library The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis - Zhu - 2015 - Clinical Cardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/558e00b3-fc71-43f8-8540-c764e6e7fd11/clc22435-fig-0002-m.jpg)
The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis - Zhu - 2015 - Clinical Cardiology - Wiley Online Library
![Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis](https://becarispublishing.com/cms/10.2217/cer.15.48/asset/bf2c0adb-2209-4399-a4d7-c7da02e480bc/assets/images/large/figure1.jpg)
Antithrombotic use and bleeding risk in patients with atrial fibrillation: findings from a multipayer analysis
![Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation | Circulation Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation | Circulation](https://www.ahajournals.org/cms/asset/d9d74bd2-4103-4f1f-aeb0-ed8c388589c3/circulationaha.111.060061.fp.png)
Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation | Circulation
![M. Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X M. Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X](https://pbs.twimg.com/media/DnYkJP0UUAAJwMg.jpg)
M. Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X
![EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of](https://pbs.twimg.com/media/ElPNWqDWMAAsQB-.jpg:large)
EHRAPresident on X: "14/24 Well-known: oral #anticoagulation should be considered if CHA2DS2-VASc ≥1 in males and ≥2 in females. In patients with #AFib initially at low risk of stroke, first reassessment of
![M. Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X M. Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X](https://pbs.twimg.com/media/DnYkH6WUYAABUzV.jpg)
M. Khurram Afzal MD on X: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / X
CorConsult Rx - #Repost @ambcarerx ・・・ With Atrial Fibrillation, the largest concern is the risk of stroke, as blood pooling (stasis) can occur and cause a clot formation. Because of this, we
![The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis - Zhu - 2015 - Clinical Cardiology - Wiley Online Library The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis - Zhu - 2015 - Clinical Cardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0df6c45f-1850-4ddb-bc3d-4cad1a661a7d/clc22435-fig-0001-m.jpg)
The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis - Zhu - 2015 - Clinical Cardiology - Wiley Online Library
![Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions](https://www.ebmedicine.net/media_library/images/MDCalc/CHA2DS2.png)
Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)